2024 Urology for the Primary Care Provider: Back to the Basics

Saturday, April 13, 2024, 8:00 AM - 12:10 PM PST, Online


This virtual activity will bring together expert faculty and participants involved in the care of patients with urologic conditions to discuss current and new concepts in diagnosis and treatment for male and female patients. This activity will explore management of stones, BPH treatment options, elevated PSA, recurrent UTIs, sexual dysfunction and the medical management of transgender patients.

1. Apply evidence-based medicine to improve the diagnosis, treatment and management of patients with urologic conditions
2. Assess current and evolving practices in the treatment of urolithiasis, prostate cancer and bladder cancer to define outcomes and treatment options for patients
3. Counsel male patients on a variety of urologic issues including PSA screening and infertility
4. Discuss the appropriate use of robotic surgery as an option for management of certain urologic conditions
5. Integrate best-practice recommendations to meet the needs of transgender and LGBTQ patients
6. Apply acquired knowledge to improve the management of adults with congenital urological abnormalities

Registration is complimentary for this activity, however pre-registration is required.  The activity Zoom link will be provided in the confirmation email that you will receive after completing the Registration process using the "Register” link above.  For any questions regarding registration, please contact [email protected].

---

Virtual Activity:  
By registering for the virtual activity, you will be able to view presentations, hear live audio, and interact online. This virtual activity will be fully web-based, and you will need a computer/laptop or tablet, audio and an internet connection. Details will be emailed to all attendees before the activity. Please be aware that you are not authorized to record, copy or share content in any manner.

---

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement
Cedars-Sinai Medical Center designates this Live Activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician AMA Attendance
Attendance credit will be provided to other healthcare professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.  

 

American Board of Internal Medicine (ABIM) MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

How do you get the MOC Points?
Before earning any MOC points, you must:

 

•  Log into your account in the CME Portal (https://cedars.cloud-cme.com/)
• Update your profile with your board diplomate number and date of birth.
• Points will not be awarded retrospectively.

AMA PRA Category 1 Credit(s)™ (MD, DO) (3.75 hours), ABIM MOC Part 2 (3.75 hours), Non-Physician AMA Attendance (3.75 hours)

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, April 13, 2024